Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

You may be eligible if

• 1. Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation
• 2. Age 18 years or older
• 3. Patients with severe hypertension as defined SBP greater than 180 mmHg and DBP greater than 95 mmHg at randomisation
• 4. Ability to stop any current antihypertensive therapy without unacceptable risk to the patient (Investigators discretion)